Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003)

To assess longer-term efficacy and safety of ofatumumab up to 6 years in people with MS early in the disease course (EDSS≤3) and without high disease activity.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211158
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003)

Christian Hentschke, Katrin Schuh, Gereon Nelles, Tjalf Ziemssen
Neurology
Systemic Sclerosis and Related Diseases
article

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003)

Christian Hentschke, Katrin Schuh, Gereon Nelles, Tjalf Ziemssen
article en

Abstract

To assess longer-term efficacy and safety of ofatumumab up to 6 years in people with MS early in the disease course (EDSS≤3) and without high disease activity.

NeurologyVol. 104(7_Supplement_1)
Novartis (France) (FR), University Hospital Carl Gustav Carus (DE)
Zero hunger
Openalex Percentile: Top 90%
Systemic Sclerosis and Related Diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003) — Christian Hentschke, Katrin Schuh, et al. · Neurology (2025) | TGRS Research Map | TGRS